Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia

Worldwide, thyroid cancer accounts for some 10% of total cancer incidence, most markedly for females. Thyroid cancer radiotherapy, typically using (131)I (T(1/2) 8.02 days; β(−) max energy 606 keV, branching ratio 89.9%), is widely adopted as an adjunct to surgery or to treat inoperable cancer and h...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mohammed, H. I., Sulieman, A., Mayhoub, Fareed H., Salah, Hassan, Lagarde, Celestino, Alkhorayef, M., Aldhebaib, Ali, Kappas, C., Bradley, D. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282852/
https://www.ncbi.nlm.nih.gov/pubmed/34267237
http://dx.doi.org/10.1038/s41598-021-93342-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282852/
https://www.ncbi.nlm.nih.gov/pubmed/34267237
http://dx.doi.org/10.1038/s41598-021-93342-1

Ejemplares similares